You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
輔仁藥業(600781.SH)逾期債務本息合計7.76億元
格隆匯 08-19 20:14

格隆匯8月19日丨輔仁藥業(600781.SH)公佈,公司因前期建設項目資本投入較大,2018年募集配套資金的定向增發融資終止,沒能及時補充營運資金。公司2019年資金緊張並出現週轉困難,導致公司及子、孫公司的部分債務出現逾期。截止公告日,逾期債務本息合計金額約7.76億元。

公司及子、孫公司可能會面臨需支付相關違約金、滯納金和罰息等情況,同時因公司為子、孫公司的上述部分負債提供連帶責任保證,可能會承擔相應的保證責任,並將會增加公司及子、孫公司的財務費用。

目前公司及下屬公司正在積極與有關各方積極協商,包括部分償還、增加擔保等方式努力達成債務和解方案。公司將加快回收應收賬款等方式全力籌措償債資金,並向債權人申請免除或減少由此形成的違約金、滯納金和罰息等。上述措施正在溝通中,尚未形成實質性解決方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account